ChatGPT: Exploring the Role of Cybersecurity in the Protection of Medical Information
Mesopotamian Journal of CyberSecurity · 01.02.2023 · 2023 · 18-21
DOI: 10.58496/mjcs/2023/004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mesopotamian Journal of CyberSecurity, online erschienen am 01.02.2023. Verfasst von Maad Mijwil und 2 weiteren Autor:innen. Die Arbeit wurde bisher 127-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
ChatGPT is a large language model developed by OpenAI. It is trained on a dataset of conversational text and can be used to generate human-like responses to prompts in a variety of languages and formats. It can be used for tasks such as chatbots, language translation, and text completion. The role of ChatGPT is to generate human-like text based on a given prompt or context. It can be used in a variety of applications such as chatbots, language translation, text completion, and question answering. Additionally, it can be fine-tuned for specific tasks such as generating product descriptions or summarizing articles. It can also be used to generate creative writing such as poetry and stories. It can be integrated into a wide range of industries from customer service to entertainment, to research.
Zitieren
APA
Mijwil, M., Aljanabi, M., & Ali, A. H. (2023). ChatGPT: Exploring the Role of Cybersecurity in the Protection of Medical Information. Mesopotamian Journal of CyberSecurity, 2023, 18-21. https://doi.org/10.58496/mjcs/2023/004
Vancouver
Mijwil M, Aljanabi M, Ali AH. ChatGPT: Exploring the Role of Cybersecurity in the Protection of Medical Information. Mesopotamian Journal of CyberSecurity. 2023;2023:18-21. doi:10.58496/mjcs/2023/004
BibTeX
@article{Mijwil2023,
author = {Mijwil, Maad and Aljanabi, Mohammad and Ali, Ahmed Hussein},
title = {ChatGPT: Exploring the Role of Cybersecurity in the Protection of Medical Information},
journal = {Mesopotamian Journal of CyberSecurity},
year = {2023},
volume = {2023},
pages = {18--21},
doi = {10.58496/mjcs/2023/004}
}
EUVIMED